ClinVar Miner

Submissions for variant NM_000059.3(BRCA2):c.9117+16T>G (rs780689895)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV000551409 SCV000635718 likely benign Hereditary breast and ovarian cancer syndrome 2017-02-05 criteria provided, single submitter clinical testing
Integrated Genetics/Laboratory Corporation of America RCV000586781 SCV000695214 uncertain significance not provided 2016-03-14 criteria provided, single submitter clinical testing Variant summary: Variant affects a non-conserved nucleotide located in an intronic region. 4/5 in silico tools via Alamut predict the variant to create a splice donor site while mutation taster predicts the variant to be neutral. It was found in the large and broad cohorts of the ExAC project at an allele frequency of 0.00086% which does not exceed the maximal expected allele frequency of a disease causing BRCA2 variant (0.075%) to exclude pathogenicity. The variant has not, to our knowledge, been reported in affected individuals via publications and nor evaluated for functional impact by in vivo/vitro studies. Due to the absence of clinical data, and the lack of functional studies, the variant was classified as a variant of uncertain significance (VUS) until more information becomes available.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.